Study visit (mean ± SD years from baseline) | ||||||||
---|---|---|---|---|---|---|---|---|
Baseline n = 3857 | 1st follow-up n = 2300 (6.0 ± 1.2 years) | 2nd follow-up n = 1336 (12.2 ± 1.5 years) | 3rd follow-up n = 454 (18.4 ± 1.5 years) | |||||
Characteristics† | n | % | n | % | n | % | n | % |
Age (years, mean ± SD)) | 62.2 | ± 9.8 | 67.0 | ± 9.2 | 71.1 | ± 7.8 | 74.9 | ± 6.7 |
Original cohort (vs enrichment) | 2732 | 70.8 | 1617 | 70.3 | 960 | 71.9 | 454 | 100 |
Men | 1495 | 38.8 | 808 | 35.1 | 461 | 34.5 | 189 | 41.6 |
African American | 1269 | 32.9 | 710 | 30.9 | 403 | 30.2 | 114 | 25.1 |
< 12 years education | 1412 | 36.6 | 701 | 30.5 | 298 | 22.3 | 68 | 15.0 |
Hip injury | 245 | 6.4 | 200 | 8.7 | 125 | 9.4 | 52 | 11.5 |
Obesity (BMI ≥ 30 kg/m2) | 1543 | 40.0 | 1061 | 46.1 | 663 | 49.6 | 222 | 48.9 |
Prevalent DM | 532 | 13.8 | 457 | 19.9 | 340 | 25.4 | 127 | 28.0 |
Incident DM | 196 | 8.5 | 114 | 8.5 | 43 | 9.5 | ||
Prevalent CVD | 855 | 22.2 | 734 | 31.9 | 557 | 41.7 | 217 | 47.8 |
Incident CVD | 302 | 13.1 | 159 | 11.9 | 50 | 11.0 | ||
Hip symptoms (max)$ | ||||||||
None | 2403 | 62.3 | 1512 | 65.7 | 928 | 69.5 | 300 | 66.1 |
Mild | 405 | 10.5 | 251 | 10.9 | 137 | 10.3 | 46 | 10.1 |
Moderate | 645 | 16.7 | 343 | 14.9 | 181 | 13.5 | 44 | 9.7 |
Severe | 375 | 9.7 | 194 | 8.4 | 90 | 6.7 | 64 | 14.1 |
State definitions | ||||||||
No rHOA or symptoms | 1743 | 45.2 | 947 | 41.2 | 531 | 39.7 | 160 | 35.2 |
Asymptomatic rHOA | 736 | 19.1 | 564 | 24.5 | 421 | 31.5 | 154 | 33.9 |
Hip symptoms only | 967 | 25.1 | 505 | 22.0 | 201 | 15.0 | 71 | 15.6 |
SxHOA | 411 | 10.7 | 284 | 12.3 | 183 | 13.7 | 69 | 15.2 |